Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.

The American journal of cardiology - 1 Aug 2020

Donnellan Eoin, Wazni Oussama M, Saliba Walid I, Hanna Mazen, Kanj Mohamed, Patel Divyang R, Wilner Bryan, Kochar Arshneel, Jaber Wael A

Abstract excerpt

Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized infiltrative cardiomyopathy in which conduction system disease is common. The aim of our study was to define the incidence and prevalence of high-grade atrioventricular (AV) block requiring pacemaker implantation in our quaternary referral center. This was a single-center retrospective cohort study of 369 consecutive patients with ATTR-CA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial
Share to Amyloidosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Atrioventricular Block

Share to Bundle-Branch Block

Share to Cardiac Pacing, Artificial

Share to Mortality

Share to Prealbumin

Share to Sick Sinus Syndrome

Source

Identifiers

PMID: 32650908
DOI: 10.1016/j.amjcard.2020.05.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.PMID 32650908Read ↗

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.Semantic proximity Read ↗

ATTR Epidemiology, Genetics, and Prognostic FactorsSemantic proximity Read ↗

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Specificities of amyloid cardiomyopathy caused by transthyretin V30 mutation.Semantic proximity Read ↗

Cardiac Care of Patients with Cardiac Amyloidosis.Semantic proximity Read ↗

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Semantic proximity Read ↗

Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors, and tafamidis treatment outcomes.Semantic proximity Read ↗

Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Semantic proximity Read ↗

Cardiac transthyretin amyloidosis.Semantic proximity Read ↗

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathySemantic proximity Read ↗

Amyloid Cardiomyopathy.Semantic proximity Read ↗

Not So Rare After All: Rethinking Hereditary Transthyretin AmyloidosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.